AIM ImmunoTech Inc. (AIM)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 70K 140K 210K Q3 '24: 190K Q4 '24: 170K Q1 '25: 146K Q2 '25: 121K Q3 '25: 112K Q4 '25: 88K Q1 '26: 94K Q2 '26: 95K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income TTM

-30M -20M -10M 0 10M 20M 30M Q3 '24: -27.9M Q4 '24: -19.8M Q1 '25: -17.7M Q2 '25: -16.6M Q3 '25: -14.6M Q4 '25: -11.7M Q1 '26: -10.3M Q2 '26: -11.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-27M -18M -9M 0 9M 18M 27M Q3 '24: -23.9M Q4 '24: -17.3M Q1 '25: -15.2M Q2 '25: -16.2M Q3 '25: -15.8M Q4 '25: -14M Q1 '26: -13.3M Q2 '26: -14.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 50K 100K 150K Q3 '24: 36K Q4 '24: 31K Q1 '25: 33K Q2 '25: 35K Q3 '25: 95K Q4 '25: 128K Q1 '26: 122K Q2 '26: 117K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

-24M -16M -8M 0 8M 16M 24M Q3 '24: -20.7M Q4 '24: -14.9M Q1 '25: -12.4M Q2 '25: -11M Q3 '25: -12.9M Q4 '25: -11M Q1 '26: -11.3M Q2 '26: -14.4M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-12M -8M -4M 0 4M 8M 12M Q3 '17: -9.3M Q4 '17: -8M Q3 '19: -9.3M Q4 '19: -9.1M Q1 '20: -10.9M Q2 '20: -9.4M Q3 '20: -9.8M Q4 '20: -10.4M Q3 '17 Q4 '17 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q1 '24: 49.5M Q2 '24: 528.4K Q3 '24: 576.8K Q1 '25: 703.3K Q2 '25: 759.3K Q3 '25: 2.1M Q1 '26: 4.4M Q2 '26: 17.1M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-21.00 -14.00 -7.00 0.00 7.00 14.00 21.00 Q3 '23: -0.43 Q4 '23: -0.60 Q1 '24: -0.64 Q2 '24: -3.54 Q3 '24: -9.38 Q4 '24: -19.04 Q1 '26: -3.24 Q2 '26: 0.01 Q3 '23 Q4 '23 Q1 '24 Q2 '24 Q3 '24 Q4 '24 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.